Merit Medical (MMSI) announced that its board of directors unanimously appointed F. Ann Millner, formerly Merit’s lead independent director, as chair of the board effective January 5. Millner has served as a director of Merit since 2015 and as the lead independent director since July 2021. Fred Lampropoulos informed the board of directors of his resignation as a director and chair of the Board on January 4.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMSI:
- Merit Medical price target raised to $99 from $93 at Canaccord
- Merit Medical price target raised to $108 from $103 at Baird
- Hold Rating for Merit Medical Systems Due to Pending Long-term Data and Pricing Challenges for WRAPSODY Stent
- Merit Medical price target lowered to $93 from $104 at Canaccord
- Merit Medical price target lowered to $95 from $103 at Wells Fargo